News
-
-
PRESS RELEASE
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4
Sanofi obtient la désignation de médicament orphelin pour le rilzabrutinib dans l'UE contre la maladie liée aux IgG4. Étude de phase 2 positive présentée à l'EULAR 2025 -
-
-
-
-
PRESS RELEASE
Schlatter achieves a slightly positive operating result and a negative consolidated result in the first half of 2025. A profit is targeted for the year as a whole.
Schlatter achieves slightly positive operating result but reports negative consolidated result in H1 2025. Targeting full-year profit amid challenging market conditions -
-
PRESS RELEASE
Stillwater Critical Minerals Closes Non-Brokered Private Placement Financing for Gross Proceeds of $8.78 Million
Stillwater Critical Minerals Corp. announces closing of non-brokered private placement financing, raising over $8.78 million. Funds to be used for exploration projects and working capital -
